Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short-term Investments (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Short-term Investments data on record, last reported at $652000.0 in Q4 2025.

  • For Q4 2025, Short-term Investments rose 12.41% year-over-year to $652000.0; the TTM value through Dec 2025 reached $652000.0, up 12.41%, while the annual FY2025 figure was $652000.0, 12.41% up from the prior year.
  • Short-term Investments reached $652000.0 in Q4 2025 per ORGO's latest filing, up from $627000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $812000.0 in Q4 2022 and bottomed at $487000.0 in Q3 2021.
  • Average Short-term Investments over 5 years is $616650.0, with a median of $599000.0 recorded in 2021.
  • Peak YoY movement for Short-term Investments: skyrocketed 184.09% in 2021, then crashed 38.67% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $599000.0 in 2021, then soared by 35.56% to $812000.0 in 2022, then plummeted by 38.67% to $498000.0 in 2023, then rose by 16.47% to $580000.0 in 2024, then grew by 12.41% to $652000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $652000.0 in Q4 2025, $627000.0 in Q3 2025, and $659000.0 in Q2 2025.